Polymorphisms in UGT2B4 and susceptibility to pancreatic cancer
- PMID: 25932223
- PMCID: PMC4402870
Polymorphisms in UGT2B4 and susceptibility to pancreatic cancer
Abstract
As an important enzyme in the conjugation phase of drug clearance, UGT2B4 helps metabolize various endogenous and exogenous substances, and polymorphisms in the corresponding gene can influence enzyme activity. This study investigated the association between polymorphisms in UGT2B4 and the risk of developing pancreatic cancer in Han Chinese individuals. A hospital-based case-control study was conducted with 1579 healthy controls and 406 pancreatic cancer patients from China. Genomic DNA was obtained from peripheral blood lymphocytes. Time-of-flight mass spectrometry was used to genotype polymorphic loci in UGT2B4, and the association between these polymorphisms and susceptibility to pancreatic cancer was expressed as odds ratios (ORs) with 95% confidence intervals (CIs), as calculated using multivariable logistic regression analysis. The rs1131878C > T polymorphism (NT_016354.20: g.10558805C > T) in UGT2B4 was associated with an increased pancreatic cancer risk. Compared to the C/C genotype, the C/T genotype conferred 1.39 times higher the pancreatic cancer risk (95% CI = 1.09-1.77; P = 0.007), and the T/T genotype conferred 2.97 times higher the pancreatic cancer risk (95% CI = 1.24-7.08; P = 0.014). In contrast, compared with the A/A genotype, the A/C genotype at the rs3822179 locus in UGT2B4 (NT_016354.20: g.10569096C > A) bestowed a 20% risk reduction (OR = 0.80, 95% CI = 0.67-0.95; P = 0.011). However, the risk was not significantly reduced with the C/C genotype (OR = 0.77, 95% CI = 0.52-1.14, P = 0.191). Polymorphisms in UGT2B4 affect the risk of pancreatic cancer occurrence in Han Chinese individuals.
Keywords: UGT2B4; hereditary susceptibility; pancreatic cancer; polymorphism.
Figures

Similar articles
-
Association between PPARG genetic polymorphisms and ischemic stroke risk in a northern Chinese Han population: a case-control study.Neural Regen Res. 2019 Nov;14(11):1986-1993. doi: 10.4103/1673-5374.259621. Neural Regen Res. 2019. PMID: 31290457 Free PMC article.
-
Association of Genetic Polymorphisms in UDP-Glucuronosyltransferases 2B17 with the Risk of Pancreatic Cancer in Chinese Han Population.Clin Lab. 2015;61(12):1905-10. doi: 10.7754/clin.lab.2015.150329. Clin Lab. 2015. PMID: 26882814
-
Absence of significant association between UGT2B4 genetic variants and the susceptibility to anti-tuberculosis drug-induced liver injury in a Western Chinese population.J Clin Pharm Ther. 2021 Feb;46(1):66-73. doi: 10.1111/jcpt.13132. Epub 2020 Mar 14. J Clin Pharm Ther. 2021. PMID: 32170986
-
Association between vascular endothelial growth factor gene polymorphisms and age-related macular degeneration in a Polish population.Exp Mol Pathol. 2009 Dec;87(3):234-8. doi: 10.1016/j.yexmp.2009.09.005. Epub 2009 Sep 15. Exp Mol Pathol. 2009. PMID: 19761764
-
[Association of single nucleotide polymorphisms in PAI-1 with breast cancer susceptibility and prognosis].Zhonghua Bing Li Xue Za Zhi. 2016 Aug 8;45(8):533-9. doi: 10.3760/cma.j.issn.0529-5807.2016.08.008. Zhonghua Bing Li Xue Za Zhi. 2016. PMID: 27510778 Chinese.
Cited by
-
A comprehensive assessment of single nucleotide polymorphisms associated with pancreatic cancer risk: A protocol for systematic review and network meta-analysis.Medicine (Baltimore). 2020 Jun 12;99(24):e20345. doi: 10.1097/MD.0000000000020345. Medicine (Baltimore). 2020. PMID: 32541456 Free PMC article.
-
ADME gene-driven prognostic model for bladder cancer: a breakthrough in predicting survival and personalized treatment.Hereditas. 2025 Mar 19;162(1):42. doi: 10.1186/s41065-025-00409-4. Hereditas. 2025. PMID: 40108724 Free PMC article.
-
Comprehensive Analysis Identifies the PPAR-Targeted Genes Associated with Ovarian Cancer Prognosis and Tumor Microenvironment.PPAR Res. 2023 May 11;2023:6637414. doi: 10.1155/2023/6637414. eCollection 2023. PPAR Res. 2023. PMID: 37213709 Free PMC article.
-
A systematic review and network meta-analysis of single nucleotide polymorphisms associated with pancreatic cancer risk.Aging (Albany NY). 2020 Nov 20;12(24):25256-25274. doi: 10.18632/aging.104128. Epub 2020 Nov 20. Aging (Albany NY). 2020. PMID: 33226370 Free PMC article.
References
-
- Long J, Luo GP, Xiao ZW, Liu ZQ, Guo M, Liu L, Liu C, Xu J, Gao YT, Zheng Y, Wu C, Ni QX, Li M, Yu X. Cancer statistics: current diagnosis and treatment of pancreatic cancer in Shanghai, China. Cancer Lett. 2014;346:273–277. - PubMed
-
- Guo X, Cui Z. Current diagnosis and treatment of pancreatic cancer in China. Pancreas. 2005;31:13–22. - PubMed
-
- Turgeon D, Carrier JS, Levesque E, Hum DW, Belanger A. Relative enzymatic activity, protein stability, and tissue distribution of human steroid-metabolizing UGT2B subfamily members. Endocrinology. 2001;142:778–787. - PubMed
-
- Xing D, Tan W, Lin D. Genetic polymorphisms and susceptibility to esophageal cancer among Chinese population (review) Oncol Rep. 2003;10:1615–1623. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials